Immunohistological study on the graft following all O- and xenotransplantation in recipients with preformed antibody

Complement fragment C4d deposition in peritubular capillaries in acute humoral rejection after ABO blood group-incompatible human kidney transplantation

“…Since several large-scale clinical trials demonstrated that mycophenolate mofetil (MMF) is a highly effective immunosuppressant with an acceptable safety profile, MMF has become one of the standard prophylactic immunosuppressive agents in many transplant centres (1)(2)(3)(4)(5). Mycophenolic acid (MPA) selectively inhibits the proliferation of T and B lymphocytes, thereby reducing the generation of humoral re-…”